Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114966) titled 'Letermovir Prophylaxis for Cytomegalovirus Infection in Adult Chinese Liver Transplant Recipients: A Multicenter, Double-Blind, Placebo-Controlled Clinical Study' on Dec. 19, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Cytomegalovims infections
Intervention:
The experimental group (letermovir group):The application of letermovir for the prevention of CMV infection after liver transplantation
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-19
Target Sample Size: The experimental gro...